Le Lézard
Classified in: Health
Subject: SVY

Biobanking Market Forecasts 2018-2028


NEW YORK, August 8, 2018 /PRNewswire/ -- Discover Prospects for Medical Research and Therapeutic Uses, Including Human Tissues, Stem Cells (Adult Stem Cells, Umbilical Cord), Other applications (DNA, RNA, body fluids), Leading Biobanking Companies and Key Geographies

Read the full report: https://www.reportlinker.com/p05471643

Report Details
Biobanking ? our new study reveals trends, R&D progress, and predicted revenues
Where is the Biobanking market heading? If you are involved in this sector you must read this brand-new report. Visiongain's report shows you the potential revenues streams to 2028, assessing data, trends, opportunities and business prospects there.

Discover How to Stay Ahead
Our 266-page report provides 145 tables, charts, clearly illustrating the data presented in this research. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted drug sales at overall world market regional level, as well as giving a deep insight into the pipeline for Biobanking. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Biobanking market. See how to exploit these opportunities.

Forecasts to 2028 and other analyses reveal the commercial prospects
? In addition to revenue forecasting to 2028, our new study provides you with recent results, R&D overview, growth rates, and market shares.
? You will find original analyses, with business outlooks and developments.
? Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and following Biobanking Submarkets:

Biobanking for Research:

Human Tissue:
? Commercial
? Public
? Stem Cells
? Others (DNA, Blood fluids etc.)

Biobanking for Therapeutic Use:
? Umbilical Cord Banking
? Adult Stem Cell Banking

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 12 leading national markets:
? US
? Germany
? France
? The UK
? Spain
? Italy
? The Netherlands
? Japan
? China
? India
? Brazil
? Russia
? RoW

Our analysis shows activities of biobanks, including these organisations:
? Stemgent
? Biopta
? BioServe
? Coriell Institute for Medical Research
? Cord Blood America
? Cryo-Cell International.

And other companies, including these:
? China Cord Blood Corp
? LifebankUSA
? ViaCord
? Cord Blood Registry
? Biogenea Pharmaceuticals
? StemLife
? Caladrius Biosciences.

There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, China, India and the US in particular, will continue to achieve high revenue growth to 2028.
Leading companies and the potential for market growth
Overall world revenue for Biobanking will surpass $35bn in 2023, our work calculates. This will be driven by the use of biobanking in drug development and medical research, as well as the expected rise in number of commercial biobanks over the forecast period
Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Biobanking Market report helps you

In summary, our 266-page report provides you with the following knowledge: 
? Revenue forecasts to 2028 for the Biobanking market and Leading Submarkets ? discover the industry's prospects, finding the most lucrative places for investments and revenues 
? Revenue forecasts to 2028 for 12 of the leading national markets ? US, Germany, France, UK, Italy, Spain, Netherlands, Japan, Russia, China, India, Brazil 
? Discussion of what stimulates and restrains companies and the market 
? Prospects for established firms and those seeking to enter the market ? including company profiles for 16 companies involved in commercial biobanking and biobanking for therapeutic use 

Read the full report: https://www.reportlinker.com/p05471643

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker


These press releases may also interest you

at 00:39
World Malaria Day is marked each year on April 25. World Health Organization (WHO) gave as the theme for World Malaria Day 2024 Accelerating the fight against malaria for a more equitable world. WHO stated that malaria not only continues to directly...

25 avr 2024
The report titled "Anti-Adhesion Products Market by Product Type (Natural Adhesion Barriers, Synthetic Adhesion Barriers), Product Form (Film Formulation, Gel Formulation, Liquid Formulation), Application, End-User - Global Forecast 2024-2030" is now...

25 avr 2024
Product: Meat and vegetable products Issue: Food - Microbial Contamination - Listeria Distribution:British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

25 avr 2024
The report titled "Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Global...

25 avr 2024
Greenbrook TMS Inc. ("Greenbrook" or the "Company") today announced its fiscal year ended December 31, 2023 ("Fiscal 2023") operational and financial results. All values in this news release are in United States dollars, unless otherwise stated....

25 avr 2024
AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an alternative to the costly branded...



News published on and distributed by: